Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Artificial Intelligence (AI) in Medical Diagnostics Market, by Application
1.4.2 LAMEA Artificial Intelligence (AI) in Medical Diagnostics Market, by End User
1.4.3 LAMEA Artificial Intelligence (AI) in Medical Diagnostics Market, by Component
1.4.4 LAMEA Artificial Intelligence (AI) in Medical Diagnostics Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition and scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Approvals and Trials
3.3 Market Share Analysis, 2021
3.4 Top Winning Strategies
3.4.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.4.2 Key Strategic Move: (Product Launches and Product Expansions: 2018, Nov – 2022, Oct) Leading Players
Chapter 4. LAMEA Artificial Intelligence (AI) in Medical Diagnostics Market by Application
4.1 LAMEA In Vivo Diagnostics Market by Country
4.2 LAMEA Artificial Intelligence (AI) in Medical Diagnostics Market by In Vivo Diagnostics Specialty Type
4.2.1 LAMEA Radiology Market by Country
4.2.2 LAMEA Cardiology Market by Country
4.2.3 LAMEA Neurology Market by Country
4.2.4 LAMEA Obstetrics/gynecology Market by Country
4.2.5 LAMEA Ophthalmology Market by Country
4.2.6 LAMEA Others Market by Country
4.3 LAMEA Artificial Intelligence (AI) in Medical Diagnostics Market by In Vivo Diagnostics Modality Type
4.3.1 LAMEA Computed Tomography Market by Country
4.3.2 LAMEA X-Ray & Ultrasound Market by Country
4.3.3 LAMEA Magnetic Resonance Imaging Market by Country
4.3.4 LAMEA Others Market by Country
4.4 LAMEA In Vitro Diagnostics Market by Country
Chapter 5. LAMEA Artificial Intelligence (AI) in Medical Diagnostics Market by End User
5.1 LAMEA Hospitals Market by Country
5.2 LAMEA Diagnostics Imaging Centers Market by Country
5.3 LAMEA Diagnostics Laboratories Market by Country
5.4 LAMEA Others Market by Country
Chapter 6. LAMEA Artificial Intelligence (AI) in Medical Diagnostics Market by Component
6.1 LAMEA Services Market by Country
6.2 LAMEA Software Market by Country
Chapter 7. LAMEA Artificial Intelligence (AI) in Medical Diagnostics Market by Country
7.1 Brazil Artificial Intelligence (AI) in Medical Diagnostics Market
7.1.1 Brazil Artificial Intelligence (AI) in Medical Diagnostics Market by Application
7.1.1.1 Brazil Artificial Intelligence (AI) in Medical Diagnostics Market by In Vivo Diagnostics Specialty Type
7.1.1.2 Brazil Artificial Intelligence (AI) in Medical Diagnostics Market by In Vivo Diagnostics Modality Type
7.1.2 Brazil Artificial Intelligence (AI) in Medical Diagnostics Market by End User
7.1.3 Brazil Artificial Intelligence (AI) in Medical Diagnostics Market by Component
7.2 Argentina Artificial Intelligence (AI) in Medical Diagnostics Market
7.2.1 Argentina Artificial Intelligence (AI) in Medical Diagnostics Market by Application
7.2.1.1 Argentina Artificial Intelligence (AI) in Medical Diagnostics Market by In Vivo Diagnostics Specialty Type
7.2.1.2 Argentina Artificial Intelligence (AI) in Medical Diagnostics Market by In Vivo Diagnostics Modality Type
7.2.2 Argentina Artificial Intelligence (AI) in Medical Diagnostics Market by End User
7.2.3 Argentina Artificial Intelligence (AI) in Medical Diagnostics Market by Component
7.3 UAE Artificial Intelligence (AI) in Medical Diagnostics Market
7.3.1 UAE Artificial Intelligence (AI) in Medical Diagnostics Market by Application
7.3.1.1 UAE Artificial Intelligence (AI) in Medical Diagnostics Market by In Vivo Diagnostics Specialty Type
7.3.1.2 UAE Artificial Intelligence (AI) in Medical Diagnostics Market by In Vivo Diagnostics Modality Type
7.3.2 UAE Artificial Intelligence (AI) in Medical Diagnostics Market by End User
7.3.3 UAE Artificial Intelligence (AI) in Medical Diagnostics Market by Component
7.4 Saudi Arabia Artificial Intelligence (AI) in Medical Diagnostics Market
7.4.1 Saudi Arabia Artificial Intelligence (AI) in Medical Diagnostics Market by Application
7.4.1.1 Saudi Arabia Artificial Intelligence (AI) in Medical Diagnostics Market by In Vivo Diagnostics Specialty Type
7.4.1.2 Saudi Arabia Artificial Intelligence (AI) in Medical Diagnostics Market by In Vivo Diagnostics Modality Type
7.4.2 Saudi Arabia Artificial Intelligence (AI) in Medical Diagnostics Market by End User
7.4.3 Saudi Arabia Artificial Intelligence (AI) in Medical Diagnostics Market by Component
7.5 South Africa Artificial Intelligence (AI) in Medical Diagnostics Market
7.5.1 South Africa Artificial Intelligence (AI) in Medical Diagnostics Market by Application
7.5.1.1 South Africa Artificial Intelligence (AI) in Medical Diagnostics Market by In Vivo Diagnostics Specialty Type
7.5.1.2 South Africa Artificial Intelligence (AI) in Medical Diagnostics Market by In Vivo Diagnostics Modality Type
7.5.2 South Africa Artificial Intelligence (AI) in Medical Diagnostics Market by End User
7.5.3 South Africa Artificial Intelligence (AI) in Medical Diagnostics Market by Component
7.6 Nigeria Artificial Intelligence (AI) in Medical Diagnostics Market
7.6.1 Nigeria Artificial Intelligence (AI) in Medical Diagnostics Market by Application
7.6.1.1 Nigeria Artificial Intelligence (AI) in Medical Diagnostics Market by In Vivo Diagnostics Specialty Type
7.6.1.2 Nigeria Artificial Intelligence (AI) in Medical Diagnostics Market by In Vivo Diagnostics Modality Type
7.6.2 Nigeria Artificial Intelligence (AI) in Medical Diagnostics Market by End User
7.6.3 Nigeria Artificial Intelligence (AI) in Medical Diagnostics Market by Component
7.7 Rest of LAMEA Artificial Intelligence (AI) in Medical Diagnostics Market
7.7.1 Rest of LAMEA Artificial Intelligence (AI) in Medical Diagnostics Market by Application
7.7.1.1 Rest of LAMEA Artificial Intelligence (AI) in Medical Diagnostics Market by In Vivo Diagnostics Specialty Type
7.7.1.2 Rest of LAMEA Artificial Intelligence (AI) in Medical Diagnostics Market by In Vivo Diagnostics Modality Type
7.7.2 Rest of LAMEA Artificial Intelligence (AI) in Medical Diagnostics Market by End User
7.7.3 Rest of LAMEA Artificial Intelligence (AI) in Medical Diagnostics Market by Component
Chapter 8. Company Profiles
8.1 Microsoft Corporation
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.5.2 Product Launches and Product Expansions:
8.1.5.3 Acquisition and Mergers:
8.1.6 SWOT Analysis
8.2 NVIDIA Corporation
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Product Launches and Product Expansions:
8.2.6 SWOT Analysis
8.3 IBM Corporation
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional & Segmental Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Product Launches and Product Expansions:
8.3.6 SWOT Analysis
8.4 Intel Corporation
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 Recent strategies and developments:
8.4.5.1 Product Launches and Product Expansions:
8.4.6 SWOT Analysis
8.5 Google LLC
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Partnerships, Collaborations, and Agreements:
8.5.5.2 Product Launches and Product Expansions:
8.5.6 SWOT Analysis
8.6 Siemens Healthineers AG (Siemens AG)
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments:
8.6.5.1 Partnerships, Collaborations, and Agreements:
8.6.5.2 Product Launches and Product Expansions:
8.6.5.3 Acquisition and Mergers:
8.6.5.4 Approvals and Trials:
8.6.6 SWOT Analysis
8.7 General Electric (GE) Co. (GE Healthcare)
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.7.5 Recent strategies and developments:
8.7.5.1 Partnerships, Collaborations, and Agreements:
8.7.5.2 Product Launches and Product Expansions:
8.7.6 SWOT Analysis
8.8 Xilinx, Inc. (Advanced Micro Devices, Inc.)
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expenses
8.8.5 Recent strategies and developments:
8.8.5.1 Partnerships, Collaborations, and Agreements:
8.8.5.2 Acquisition and Mergers:
8.9 Digital Diagnostics, Inc.
8.9.1 Company Overview
8.9.2 Recent strategies and developments:
8.9.2.1 Partnerships, Collaborations, and Agreements:
8.9.2.2 Acquisition and Mergers:
8.10. InformAI, LLC
8.10.1 Company Overview
Unique Offerings 
